(INVE-B) Investor ser. - Ratings and Ratios

Exchange: ST • Country: Sweden • Currency: SEK • Type: Common Stock • ISIN: SE0015811963

INVE-B: Health, Finance, It, Equity, Investments, Capital

Investor AB (publ) is one of the oldest and most established private equity firms globally, with a rich history dating back to 1916. Headquartered in Stockholm, Sweden, the firm operates with a dual strategy, focusing on both core investments and operating investments. For its core investments, it targets mature, middle-market buyouts and growth capital opportunities, primarily in the healthcare, financial services, IT, and fintech sectors. The firm is not afraid to take leading minority positions in listed companies, demonstrating its flexibility and strategic approach to value creation.

Geographically, Investor AB casts a wide net. While its operating investments are concentrated on medium-to-large-sized companies headquartered in Northern Europe, the firm also actively pursues opportunities in North Africa, Sub-Saharan Africa, Asia-Pacific, and Latin America, among other regions. This global outlook is complemented by a local touch, as it has deep expertise in navigating the complexities of markets like the Nordics, the Baltics, and the British Isles. The firm’s investment size typically ranges between SEK 20 million ($1.83 million) and SEK 200 million ($18.28 million), allowing it to target a broad spectrum of companies, from emerging players to established market leaders.

Investor AB employs a disciplined approach to its investments. For its operating investments, it seeks controlling stakes or significant minority positions, often taking an active role through board membership to drive strategic decisions and operational improvements. In contrast, its financial investments are typically minority stakes with a shorter investment horizon, focusing on financial holdings that offer attractive returns without the need for active involvement. The firm’s private equity investments are generally held for three to seven years, reflecting its patient, long-term approach to building value.

From a financial perspective, Investor AB is a formidable player, with a market capitalization of 969.086 billion SEK. The stock currently trades at a P/E ratio of 8.55, reflecting its stable earnings and mature business model. The price-to-book (P/B) ratio of 1.19 indicates that the market values the company’s assets at a modest premium, suggesting a balance between growth and stability. The price-to-sales (P/S) ratio of 3.66 further underscores its ability to generate revenue and cash flow from its diversified portfolio.

For investors and fund managers, Investor AB offers a unique combination of historical pedigree, strategic focus, and global reach. Its ability to balance private equity investments with financial holdings provides a diversified approach to capital deployment

Additional Sources for INVE-B Stock

Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle

INVE-B Stock Overview

Market Cap in USD 88,961m
Sector Financial Services
Industry Asset Management
GiC Sub-Industry Environmental & Facilities Services
IPO / Inception

INVE-B Stock Ratings

Growth Rating 84.3
Fundamental 32.1
Dividend Rating 67.9
Rel. Strength 1.31
Analysts -
Fair Price Momentum 287.22 SEK
Fair Price DCF 231.89 SEK

INVE-B Dividends

Dividend Yield 12m 3.48%
Yield on Cost 5y 9.38%
Annual Growth 5y 16.36%
Payout Consistency 91.6%

INVE-B Growth Ratios

Growth Correlation 3m -57.6%
Growth Correlation 12m 66%
Growth Correlation 5y 91.6%
CAGR 5y 20.85%
CAGR/Max DD 5y 0.68
Sharpe Ratio 12m 0.72
Alpha -0.25
Beta 0.755
Volatility 56.49%
Current Volume 3228.9k
Average Volume 20d 4179.6k
What is the price of INVE-B stocks?
As of April 15, 2025, the stock is trading at SEK 275.80 with a total of 3,228,851 shares traded.
Over the past week, the price has changed by +6.82%, over one month by -10.80%, over three months by -7.01% and over the past year by +7.00%.
Is Investor ser. a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, Investor ser. is currently (April 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 32.07 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of INVE-B as of April 2025 is 287.22. This means that INVE-B is currently overvalued and has a potential downside of 4.14%.
Is INVE-B a buy, sell or hold?
Investor ser. has no consensus analysts rating.
What are the forecast for INVE-B stock price target?
According to ValueRays Forecast Model, INVE-B Investor ser. will be worth about 316.6 in April 2026. The stock is currently trading at 275.80. This means that the stock has a potential upside of +14.8%.
Issuer Forecast Upside
Wallstreet Target Price 335.3 21.6%
Analysts Target Price - -
ValueRay Target Price 316.6 14.8%